HB 163

  • Kentucky House Bill
  • 2024 Regular Session
  • Introduced in House Jan 05, 2024
  • House
  • Senate
  • Governor

AN ACT relating to blood donation.

Abstract

Amend KRS 214.450 to define "COVID-19 vaccine" or "mRNA vaccine"; amend KRS 214.452 to require blood establishments to test for COVID-19 antibodies, evidence of lipid nanoparticles, and spike protein; require the administrator of any blood establishment to inquire on the donor history questionnaire whether a donor has received a COVID-19 vaccine or mRNA vaccine; require a donor to provide the name of the manufacturer of the COVID-19 vaccine the donor received; establish deferral periods for donors who have received a live attenuated COVID-19 vaccine or for donors who do not know the manufacturer of the COVID-19 vaccine the donor received, and establish deferral periods for donors who have received a diagnosis of COVID-19 or are displaying symptoms of COVID-19; amend KRS 214.458 to require blood establishments to include on the label for blood collected the laboratory test results for COVID-19.

Bill Sponsors (14)

Votes


No votes to display

Actions


Jan 05, 2024

House

introduced in House

House

to Committee on Committees (H)

Bill Text

Bill Text Versions Format
Introduced PDF

Related Documents

Document Format
No related documents.

Sources

Data on Open States is updated periodically throughout the day from the official website of the Kentucky General Assembly.

If you notice any inconsistencies with these official sources, feel free to file an issue.